Myeloproliferative neoplasms (MPNs) have a significant impact on patients’ overall health and productivity: the MPN Landmark surveyRuben A. Mesa, John Mascarenhas, Xiaomei Ma et al.|BMC Cancer|2016Cited by 194
Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark surveyRuben A. Mesa, John Mascarenhas, Sara Goldberger et al.|Cancer|2016Cited by 91
Impact of Myeloproliferative Neoplasms (MPNs) on Patients’ Overall Health and Productivity: Results from the MPN LANDMARK SURVEY in the United StatesRuben A. Mesa, John Mascarenhas, Carole B. Miller et al.|Blood|2014Cited by 14
Phlebotomy Frequency and Quality of Life and Productivity in Patients with Polycythemia Vera: Results from the MPN Landmark Survey in the United StatesSalman Fazal, Ruben A. Mesa, Carole B. Miller et al.|Blood|2015Cited by 5
Hydroxyurea Treatment History and Quality of Life in Patients with Polycythemia Vera: Results from the MPN Landmark Survey in the United StatesRuben A. Mesa, James K. Mangan, Carole B. Miller et al.|Blood|2015Cited by 5